A detailed history of Piershale Financial Group, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Piershale Financial Group, Inc. holds 112 shares of PFE stock, worth $2,863. This represents 0.0% of its overall portfolio holdings.

Number of Shares
112
Previous 110 1.82%
Holding current value
$2,863
Previous $4,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 06, 2023

BUY
$36.12 - $41.79 $72 - $83
2 Added 1.82%
112 $4,000
Q1 2023

Apr 12, 2023

BUY
$39.39 - $51.28 $39 - $51
1 Added 0.92%
110 $4,000
Q4 2022

Jan 13, 2023

BUY
$41.75 - $54.5 $4,550 - $5,940
109 New
109 $0

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $144B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Piershale Financial Group, Inc. Portfolio

Follow Piershale Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Piershale Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Piershale Financial Group, Inc. with notifications on news.